The Mundipharma global network of independent associated companies seeks to identify and accelerate the development of meaningful medicines that add value for patients and healthcare providers around the globe. Founded in the US by two physicians in 1952 and still privately owned the network has a presence in over 120 countries. As a network, we have a strong track record of building successful alliances to license, develop and market medicines that improve patientsÍ lives, while also providing attractive options to financially constrained healthcare systems. Consistent with our entrepreneurial heritage, we like to think we see what others donÍt by challenging conventional wisdom and asking different and challenging questions. We are global leaders in pain medicines, with a significant, and growing presence in our three other core therapeutic areas of respiratory, oncology and biosimilars. However, we are also open to new partnership opportunities that will enable us to realize the potential of medicines at all stages of maturity across other therapy areas. For more information see www.mundipharma.com Mundipharma International Limited is part of and provides support to the Mundipharma network.